• Home
  • News
  • Pipeline
  • Founders
  • Board of Directors
  • Management
  • Contact Us
  • More
    • Home
    • News
    • Pipeline
    • Founders
    • Board of Directors
    • Management
    • Contact Us
  • Home
  • News
  • Pipeline
  • Founders
  • Board of Directors
  • Management
  • Contact Us

Neosomeplus - Exosomes derived from immortalized Neonatal Stem Cells

NeoProgen is a pre-clinical stage company developing human neonatal heart-derived Medicinal Signaling Cells (nMSCs) and an exosome-based product for tissue repair and regeneration for the treatment of heart failure (HF) and other inflammatory diseases.

Stay Informed

Meet our team


This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept